TRPT1 Activators
TRPT1 play a crucial role in modulating its activity through various biochemical pathways, primarily involving the elevation of intracellular cyclic AMP (cAMP) levels. Forskolin, a diterpene, acts directly on adenylate cyclase to increase cAMP production. This elevation in cAMP levels leads to the activation of protein kinase A (PKA), which can phosphorylate TRPT1, culminating in the activation of its protein function. Isoproterenol, a synthetic molecule mimicking the action of endogenous catecholamines, and epinephrine, a natural catecholamine, both bind to beta-adrenergic receptors and trigger a similar cascade, resulting in PKA-mediated phosphorylation of TRPT1. Terbutaline operates in a comparable manner, targeting beta2-adrenergic receptors to boost cAMP and activate PKA. Similarly, prostaglandin E2 (PGE2) binds to its G protein-coupled receptors, and dopamine interacts with D1-like receptors, both leading to adenylate cyclase activation and subsequent cAMP-mediated activation of PKA that can then target TRPT1.
In addition to these mechanisms, other compounds affect TRPT1 activity through various signaling pathways. Histamine, upon binding to H2 receptors, prompts a rise in cAMP levels, which in turn activates PKA and can lead to TRPT1 activation. Glucagon, a hormone, also binds to its specific GPCR, eliciting an increase in cAMP and subsequent PKA activation with effects on TRPT1. Cholera toxin irreversibly activates adenylate cyclase through ADP-ribosylation of the Gs alpha subunit, leading to a sustained increase in cAMP and PKA activity, which can influence TRPT1 phosphorylation. PACAP, acting through its GPCR, similarly promotes adenylate cyclase activity and cAMP production. IBMX, in contrast, increases cAMP levels by inhibiting phosphodiesterases, thereby preventing cAMP breakdown and indirectly promoting PKA activation and TRPT1 phosphorylation. Anisomycin, although not acting directly through cAMP, activates the JNK/SAPK signaling pathway, which may lead to the expression of proteins that can phosphorylate and activate TRPT1, illustrating an alternative regulatory mechanism.
Share
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a synthetic catecholamine that acts as an agonist of beta-adrenergic receptors, causing increased production of cAMP via adenylate cyclase activation. This increase in cAMP can activate PKA which in turn may phosphorylate and activate TRPT1. | ||||||
PGE2 | 363-24-6 | sc-201225 sc-201225C sc-201225A sc-201225B | 1 mg 5 mg 10 mg 50 mg | $57.00 $159.00 $275.00 $678.00 | 37 | |
Prostaglandin E2 (PGE2) interacts with its G protein-coupled receptors (GPCRs), leading to the activation of adenylate cyclase and an increase in cAMP levels. The cAMP acts as a secondary messenger to activate PKA, which could phosphorylate TRPT1 thereby activating it. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
3-Isobutyl-1-methylxanthine (IBMX) is a non-selective inhibitor of phosphodiesterases, enzymes that break down cAMP. By inhibiting these enzymes, IBMX indirectly raises cAMP levels, thereby potentially activating PKA and subsequently TRPT1. | ||||||
Histamine, free base | 51-45-6 | sc-204000 sc-204000A sc-204000B | 1 g 5 g 25 g | $94.00 $283.00 $988.00 | 7 | |
Histamine can bind to H2 receptors which are coupled to Gs proteins that activate adenylate cyclase, leading to increased cAMP and activation of PKA. PKA can then potentially phosphorylate and activate TRPT1. | ||||||
(−)-Epinephrine | 51-43-4 | sc-205674 sc-205674A sc-205674B sc-205674C sc-205674D | 1 g 5 g 10 g 100 g 1 kg | $41.00 $104.00 $201.00 $1774.00 $16500.00 | ||
Epinephrine interacts with beta-adrenergic receptors, enhancing the production of cAMP by activating adenylate cyclase. The increase in cAMP levels activates PKA, which can phosphorylate and activate TRPT1. | ||||||
Dopamine | 51-61-6 | sc-507336 | 1 g | $290.00 | ||
Dopamine can bind to D1-like receptors, which are associated with Gs proteins that stimulate adenylate cyclase to produce cAMP. Increased cAMP activates PKA, which could lead to the phosphorylation and activation of TRPT1. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Pituitary adenylate cyclase-activating polypeptide (PACAP) binds to its specific GPCR, leading to activation of adenylate cyclase and an increase in cAMP. This can activate PKA, which could phosphorylate and functionally activate TRPT1. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a potent activator of the JNK/SAPK signaling pathway, which can lead to the activation of transcription factors that may induce the expression of proteins that could phosphorylate TRPT1, resulting in its activation. | ||||||
Terbutaline Hemisulfate | 23031-32-5 | sc-204911 sc-204911A | 1 g 5 g | $92.00 $378.00 | 2 | |
Terbutaline is a beta2-adrenergic agonist that increases intracellular cAMP by activating adenylate cyclase. The rise in cAMP activates PKA, which can then phosphorylate and activate TRPT1. | ||||||